Psyence Biomedical Ltd.
PBMWW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001985062
No open-market purchases or sales by Psyence Biomedical Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $121.6K in total; no superinvestor holds it.
Other share classesPBM
Q2 2024 vs. Q1 2024
How the institutions holding Psyence Biomedical Ltd. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 30 | 28 | −2 |
| Shares | 6.76M | 6.59M | −170.2K (−2.5%) |
| Value | $499.9K | $71.9K | −$428.1K (−85.6%) |
New holders (1)
Institutions that held Psyence Biomedical Ltd. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 200,117 | $2.10K | 0.00% |
Sold out (3)
Institutions that held Psyence Biomedical Ltd. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| EHP Funds Inc. | 1,232,748 | $86.3K |
| Mizuho Securities USA LLC | 89,325 | $4.47K |
| Schonfeld Strategic Advisors LLC | 24,300 | $1.70K |